Finding clinical endpoints and biosurrogates in preclinical knee osteoarthritis

Journal of Rheumatology

Volumn 32, Issue 6, 2005, Pages 1152-1154

  De Pablo, Paola ^a   Liang, Matthew H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; CALCIUM PYROPHOSPHATE; COLLAGEN TYPE 1; ESTROGEN RECEPTOR ALPHA; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; VITAMIN D RECEPTOR;

ANTERIOR CRUCIATE LIGAMENT; ARTHROSCOPY; CARTILAGE DEGENERATION; CHROMOSOME 1; CHROMOSOME 15; CHROMOSOME 16; CHROMOSOME 2; CHROMOSOME 20; CHROMOSOME 4; CHROMOSOME 7; CONFERENCE PAPER; DISEASE COURSE; DISEASE PREDISPOSITION; GENETIC POLYMORPHISM; GENOTYPE; HIP DYSPLASIA; HUMAN; JOINT CAVITY; KNEE INJURY; KNEE MENISCUS RUPTURE; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; LIGAMENT INJURY; MECHANICAL STRESS; MENISCECTOMY; METABOLIC DISORDER; MUSCLE WEAKNESS; NERVE INJURY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PAIN; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; TREATMENT OUTCOME;

ANTIRHEUMATIC AGENTS; BIOLOGICAL MARKERS; EARLY DIAGNOSIS; OSTEOARTHRITIS, KNEE; TREATMENT OUTCOME;

EID: 20444435473     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. Liang MH. Pushing the limits of patient-oriented outcome measurements in the search for disease modifying treatments for osteoarthritis. J Rheumatol 2004;31 Suppl 70:61-5.
2. Pham T, van der Heijde D, Lassere M, et al. Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria. J Rheumatol 2003;30:1648-54.
3. Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled? Ann Intern Med 1996;125:605-13.
4. Lohmander LS, Ostenberg A, Englund M, Roos HP. High prevalence of knee osteoarthritis, pain and functional limitations in female soccer players twelve years after anterior cruciate ligament injury. Arthritis Rheum 2004;50:3145-52.
5. Loughlin J. Genetic epidemiology of primary osteoarthritis. Curr Opin Rheumatol 2001;13:111-6.
6. Palotie A, Vaisanen P, Ott J, et al. Predisposition to familial osteoarthrosis linked to type II collagen gene. Lancet 1989;1:924-7.
7. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15:1833-40.
8. Roos EM, Roos HP, Ekdahl C, Lohmander LS. Knee injury and Osteoarthritis Outcome Score (KOOS) - validation of a Swedish version. Scand J Med Sci Sports 1998;8:439-48.
9. Buckland-Wright JC, Macfarlane DG, Lynch JA, Jasani MK, Bradshaw CR. Joint space width measures cartilage thickness in osteoarthritis of the knee: high resolution plain film and double contrast macroradiographic investigation. Ann Rheum Dis 1995;54:263-8.
10. Altman R, Brandt K, Hochberg M, et al. Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. Osteoarthritis Cartilage 1996;4:217-43.
11. Ravaud P, Ayral X, Dougados M. Radiologic progression of hip and knee osteoarthritis. Osteoarthritis Cartilage 1999;7:222-9.
12. Ravaud P, Giraudeau B, Auleley GR, Edouard-Noel R, Dougados M, Chastang C. Assessing smallest detectable change over time in continuous structural outcome measures: application to radiological change in knee osteoarthritis. J Clin Epidemiol 1999;52:1225-30.
13. Tiderius CJ, Olsson LE, Leander P, Ekberg O, Dahlberg L. Delayed gadolinium-enhanced MRI of cartilage (dGEMERIC) in early knee osteoarthritis. Magn Reson Med 2003;49:488-92.